Eye imaging study aims to predict who will lose sight from AMD
NCT ID NCT05698316
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study collected eye images from 1,000 people with intermediate age-related macular degeneration (AMD) to create a detailed database. Researchers will analyze these images to find signs that predict whether the disease will worsen to advanced stages. The goal is to improve early detection and monitoring, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict which patients with intermediate AMD will develop vision loss, enabling earlier monitoring or treatment.
- What could go wrong
- This is an observational study that builds a database, not a treatment trial. It may not lead to immediate clinical changes, and the predictive models need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AIBILI-CEC (AIBILI- Clinical Trials Centre)
Coimbra, Portugal
-
Clinical Eye Research Centre - St. Paul's Eye Unit, Royal Liverpool University Hospital
Liverpool, United Kingdom
-
Clinical Trial Unit, Dep. Ophth., Gloucestershire Hospitals NHS Foundation Trust
Cheltenham, United Kingdom
-
Clínica Oftalmológica AIKEN / Fundación Aiken de la Comunitat Valenciana
Valencia, Spain
-
Department of Ophthalmology Justus/Liebig/University/Giessen
Giesen, Germany
-
Department of Ophthalmology Porto Medical School / Hospital S. João
Porto, Portugal
-
Department of Ophthalmology Radboud University Medical Centre Nijmegen
Nijmegen, Netherlands
-
Department of Ophthalmology St. Franziskus/Hospital Münster
Münster, Germany
-
Department of Ophthalmology University of Bonn
Bonn, Germany
-
Department of Ophthalmology University of Freiburg
Freiburg im Breisgau, Germany
-
Department of Ophthalmology University of Muenster Medical Center
Münster, Germany
-
Department of Ophthalmology University of Udine
Udine, Italy
-
Department of Ophthalmology, University Hospital, Nantes
Nantes, France
-
Espaço Médico de Coimbra
Coimbra, Portugal
-
Eye Clinic Sulzbach, Knappschaft Hospital Saar
Sulzbach, Germany
-
Eye Unit, University Hospital Maggiore della Carità
Novara, Italy
-
Institut Català de Retina (ICR), Clinical Trial Unit
Barcelona, Spain
-
Institut de la Màcula Centro Médico Teknon
Barcelona, Spain
-
Instituto de Oftalmologia Dr. Gama Pinto
Lisbon, Portugal
-
Medical Retina Service, Operative Unit Ophthalmology / MultiMedica Spa (IRCCSMM)
Milan, Italy
-
NIHR Moorfields Clinical Research Facility, Moorfields Eye Hospital, NHS Foundation Trust
London, United Kingdom
-
Royal Victoria Eye and Ear Research Foundation
Dublin, Ireland
-
Swiss Visio Retina Research Center, Swiss Visio Montchoisi
Lausanne, Switzerland
-
University Hospital Basel, University Eye Clinic, Basel
Basel, Switzerland
-
Valles Ophthalmology Research, S.L.
Barcelona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper look at the retina: new imaging technology may spot eye disease earlier
- Eye injection aims to tame leading causes of blindness
- Could a common diabetes drug help muscles heal faster after ACL surgery?
- Could light therapy help save sight in dry macular degeneration?
- Goji berry trial hopes to shield aging eyes from vision loss
- Could a simple score predict dementia in depressed seniors?